JHBP/Genor (嘉和生物) IPO: Undemanding Valuation with a Strong Investor Line-Up
JHBP/Gencor Biopharmaceutical (hereafter Gencor) is a China-based biotech company with a focus on oncology and autoimmune drugs with development...
587 Views
GoodRx IPO: A Healthy Prescription for Strong Topline Growth and Profits
GoodRx (GDRX) offers a prescription aggregation platform in the US enabling healthcare professionals to provide prices from the platform directly...
467 Views
Genor Biopharma IPO: Strong Clinical Pipeline with Some Potential Blockbusters
JHBP (CY) Holdings Ltd also known as Genor Biopharma has filed for an IPO on the Hong Kong Stock Exchange to raise about HK$2.48bn (US$320m). The...
475 Views
JHBP Holdings (Genor Biopharma) IPO Initiation: Hunting for a Cure
$ Genor Biopharma is a biopharmaceutical company focusing on developing and commercializing oncology and autoimmune drugs. Its drug candidates...
531 Views
JHBP/Genor (嘉和生物) Pre-IPO: Thoughts on Valuation
JHBP/Gencor Biopharmaceutical (hereafter Gencor) is a China based biotech company with a focus on oncology and autoimmune drugs with development...
532 Views